| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.18 | 0.01 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |